1. Home
  2. Stocks
  3. Syngene Share Price
  • Chart
  • F&O
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Syngene International Share Price

    Large Cap
    ₹910.6
    -27.6 (-2.94%)
    18 September, 2024 02:35 BSE: 539268 NSE: SYNGENE ISIN: INE398R01022

    Start SIP in Syngene International

    Start SIP

    Syngene International Performance

    Day Range

    • Low 907
    • High 943
    ₹ 910

    52 Week Range

    • Low 608
    • High 945
    ₹ 910
    • Open Price943
    • Previous Close938
    • Volume499103

    Syngene International Chart

    • Over 1 Month + 9.59%
    • Over 3 Month + 28.79%
    • Over 6 Month + 35.16%
    • Over 1 Year + 9.12%

    Syngene International Key Statistics

    P/E Ratio 74.5
    PEG Ratio 42.4
    Market Cap Cr
    Price to Book Ratio 8.6
    EPS 11.6
    Dividend 0.1
    Relative Strength Index 61.68
    Money Flow Index 78.4
    MACD Signal 27.9
    Average True Range 24.67

    Syngene International F&O

    Syngene International Futures Syngene International Option Chain

    Syngene International Investment Rating

    • Master Rating:

    • Syngene Inter has an operating revenue of Rs. 3,470.20 Cr. on a trailing 12-month basis. An annual revenue growth of 10% is good, Pre-tax margin of 18% is great, ROE of 11% is good. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 12% and 25% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 9% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 47 which is a POOR score indicating inconsistency in earnings, a RS Rating of 61 which is FAIR indicating the recent price performance, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 44 indicates it belongs to a fair industry group of Medical-Research Eqp/Svc and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Syngene International Financials
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 727865792831716994
    Operating Expenses Qtr Cr 578565592614552678
    Operating Profit Qtr Cr 148299200217163316
    Depreciation Qtr Cr 929694918988
    Interest Qtr Cr 7969610
    Tax Qtr Cr 252125291652
    Net Profit Qtr Cr 7419010010275189
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 3,2913,264
    Operating Expenses Annual Cr 2,3242,259
    Operating Profit Annual in Cr 879934
    Depreciation Cr 369359
    Interest Annual Cr 3045
    Tax Annual Cr 91128
    Net Profit Annual Cr 467473
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 913838
    Cash from Investing Activity Annual Cr -384-688
    Cash from Financing Annual Activity Cr -536-340
    Net Cash Flow Annual Cr -6-190
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 4,1923,619
    Fixed Assets Annual Cr 3,0782,386
    Total Non Current Assets Annual Cr 3,9822,964
    Total Current Assets Annual Cr 1,8522,884
    Total Assets Annual Cr 5,8345,848
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 10490
    ROE Annual % 1113
    ROCE Annual % 1314
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 3031
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 790917854910808994
    Operating Expenses Qtr Cr 620600622656596680
    Operating Profit Qtr Cr 170317232254212314
    Depreciation Qtr Cr 10711110810510296
    Interest Qtr Cr 121311131110
    Tax Qtr Cr 262027343052
    Net Profit Qtr Cr 7618911211793179
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 3,5793,264
    Operating Expenses Annual Cr 2,4742,259
    Operating Profit Annual in Cr 1,014934
    Depreciation Cr 426367
    Interest Annual Cr 4745
    Tax Annual Cr 111129
    Net Profit Annual Cr 510464
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 1,042824
    Cash from Investing Activity Annual Cr -496-656
    Cash from Financing Annual Activity Cr -551-343
    Net Cash Flow Annual Cr -5-175
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 4,2583,618
    Fixed Assets Annual Cr 3,6882,844
    Total Non Current Assets Annual Cr 4,1933,406
    Total Current Assets Annual Cr 1,9592,425
    Total Assets Annual Cr 6,1525,831
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 10690
    ROE Annual % 1213
    ROCE Annual % 1414
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 3231
    Invest in Syngene International

    Syngene International Technicals

    EMA & SMA

    Current Price
    ₹910.6
    -27.6 (-2.94%)
    pointer
    • Bullish Moving Average
    • ___
    • 13
    • Bearish Moving Average
    • ___
    • 3
    • 20 Day
    • ₹885.61
    • 50 Day
    • ₹835.25
    • 100 Day
    • ₹790.97
    • 200 Day
    • ₹756.91
    • 20 Day
    • ₹880.39
    • 50 Day
    • ₹825.55
    • 100 Day
    • ₹758.80
    • 200 Day
    • ₹737.50

    Syngene International Resistance and Support

    PIVOT
    ₹920.44
    Resistance
    First Resistance 933.62
    Second Resistance 956.63
    Third Resistance 969.82
    RSI 61.68
    MFI 78.40
    MACD Single Line 27.90
    MACD 29.36
    Support
    First Support 897.42
    Second Support 884.23
    Third Supoort 861.22

    Syngene International Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 519,836 28,762,526 55.33
    Week 589,360 25,536,969 43.33
    1 Month 1,047,647 50,077,520 47.8
    6 Month 983,980 49,444,981 50.25

    Syngene International Result Highlights

    Syngene International Synopsis

    NSE-Medical-Research Eqp/Svc

    Syngene Internationa is involved in the business activities of Scientific research and development. Company’s Total Operating Revenue is Rs. 3203.10 Cr. and Equity Capital is Rs. 402.00 Cr. for the Year ended 31/03/2024. Syngene International Ltd. is a Public Limited Listed company incorporated on 18/11/1993 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1993PLC014937 and registration number is 014937.
    Market Cap 37,766
    Sales 3,214
    Shares in Float 18.11
    No of funds 313
    Yield 0.13
    Book Value 9
    U/D Vol ratio 1.8
    LTDebt / Equity 2
    Alpha
    Beta 0.57

    Syngene International Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23Sep-23
    Promoters 54.72%54.79%54.79%54.79%
    Mutual Funds 13.63%12.59%11.93%9.09%
    Insurance Companies 1.95%1.7%1.15%0.85%
    Foreign Portfolio Investors 20.64%20.92%21.2%23.55%
    Financial Institutions/ Banks 0.01%0.01%
    Individual Investors 6.08%6.45%7.24%7.52%
    Others 2.97%3.54%3.69%4.2%

    Syngene International Management

    Name Designation
    Ms. Kiran Mazumdar Shaw Non Executive Chairman
    Mr. Jonathan Hunt Managing Director & CEO
    Mr. Sibaji Biswas Executive Director & CFO
    Prof. Catherine Rosenberg Non Executive Director
    Dr. Kush Parmar Independent Director
    Mr. Paul Blackburn Independent Director
    Ms. Sharmila Abhay Karve Independent Director
    Dr. Vijay Kuchroo Independent Director
    Mr. Nilanjan Roy Independent Director
    Ms. Vinita Bali Lead Independent Director

    Syngene International Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Syngene International Corporate Action

    Date Purpose Remarks
    2024-07-24 Quarterly Results
    2024-04-24 Audited Results & Final Dividend
    2024-01-25 Quarterly Results
    2023-10-17 Quarterly Results
    2023-07-26 Quarterly Results
    Date Purpose Remarks
    2024-06-28 FINAL Rs.1.25 per share(12.5%)Final Dividend
    2023-06-30 FINAL Rs.0.50 per share(5%)Final Dividend
    2022-07-01 FINAL Rs.0.50 per share(5%)Final Dividend
    2022-07-01 SPECIAL Rs.0.50 per share(5%)Special Dividend

    Syngene International MF Shareholding

    Name Amount(cr)
    HDFC Balanced Advantage Fund Growth 95,391
    ICICI Prudential Bluechip Fund Growth 64,223
    ICICI Prudential Balanced Advantage Fund Growth 61,103
    Kotak Equity Arbitrage Fund Growth 53,423
    ICICI Prudential Multi-Asset Fund Growth 48,201

    Syngene International FAQs

    What is Share Price of Syngene International ?

    Syngene International share price is ₹910 As on 18 September, 2024 | 02:21

    What is the Market Cap of Syngene International ?

    The Market Cap of Syngene International is ₹36655 Cr As on 18 September, 2024 | 02:21

    What is the P/E ratio of Syngene International ?

    The P/E ratio of Syngene International is 74.5 As on 18 September, 2024 | 02:21

    What is the PB ratio of Syngene International ?

    The PB ratio of Syngene International is 8.6 As on 18 September, 2024 | 02:21

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     
    footer_form

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 29/07/2024 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.